InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

Current share price for SHL : $23.020 0.21 (0.92%)+

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$11,377 Application for quotation of securities - SHL 8 Dec 2022 4:31PM $30.420 $23.020 fallen by 24.33%
$11,377 Becoming a substantial holder for MAP 2 Dec 2022 9:30AM $31.800 $23.020 fallen by 27.61%
$11,377 STRATEGIC STAKE AND COMMERCIAL PARTNERSHIP WITH MICROBA 29 Nov 2022 9:32AM $31.680 $23.020 fallen by 27.34%
$11,377 MAP: Sonic Investment & Partnership Investor Presentation 29 Nov 2022 9:18AM $31.680 $23.020 fallen by 27.34%
$11,377 MAP: Sonic Acquires 19.9% Microba Stake + Enters Partnership 29 Nov 2022 9:18AM $31.680 $23.020 fallen by 27.34%
$11,377 Change of Director's Interest Notice 24 Nov 2022 4:25PM $31.770 $23.020 fallen by 27.54%
$11,377 Change of Director's Interest Notice 24 Nov 2022 4:22PM $31.770 $23.020 fallen by 27.54%
$11,377 Notification regarding unquoted securities - SHL 18 Nov 2022 10:50AM $32.100 $23.020 fallen by 28.29%
$11,377 Notification regarding unquoted securities - SHL 18 Nov 2022 9:59AM $32.670 $23.020 fallen by 29.54%
$11,377 Final Director's Interest Notice 17 Nov 2022 2:54PM $32.520 $23.020 fallen by 29.21%
$11,377 Final Director's Interest Notice 17 Nov 2022 2:54PM $32.520 $23.020 fallen by 29.21%
$11,377 Results of Meeting 17 Nov 2022 2:34PM $32.430 $23.020 fallen by 29.02%
$11,377 Sonic 2022 AGM - CEO Presentation 17 Nov 2022 9:21AM $32.290 $23.020 fallen by 28.71%
$11,377 Chairman's Address to Shareholders 17 Nov 2022 9:20AM $32.290 $23.020 fallen by 28.71%
$11,377 Trading Update - Results for 4 months to October 2022 17 Nov 2022 9:18AM $32.290 $23.020 fallen by 28.71%
$11,377 Sonic Healthcare Sustainability Report 2022 15 Nov 2022 12:46PM $33.200 $23.020 fallen by 30.66%
$11,377 Update - Notification of buy-back - SHL 28 Oct 2022 5:30PM $32.290 $23.020 fallen by 28.71%
$11,377 Update - Notification of buy-back - SHL 27 Oct 2022 5:28PM $32.070 $23.020 fallen by 28.22%
$11,377 Update - Notification of buy-back - SHL 26 Oct 2022 5:28PM $32.240 $23.020 fallen by 28.60%
$11,377 Notification regarding unquoted securities - SHL 26 Oct 2022 4:54PM $32.240 $23.020 fallen by 28.60%
$11,377 Update - Notification of buy-back - SHL 25 Oct 2022 5:17PM $31.590 $23.020 fallen by 27.13%
$11,377 Update - Notification of buy-back - SHL 24 Oct 2022 5:27PM $31.150 $23.020 fallen by 26.10%
$11,377 Update - Notification of buy-back - SHL 20 Oct 2022 5:39PM $30.590 $23.020 fallen by 24.75%
$11,377 Update - Notification of buy-back - SHL 19 Oct 2022 5:31PM n/a $23.020 n/a
$11,377 Update - Notification of buy-back - SHL 18 Oct 2022 5:22PM $31.100 $23.020 fallen by 25.98%

226 - 250 of 834 results

Page 10 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.